Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?
Introduction Psilocybin is a naturally occurring plant alkaloid in mushrooms and a prodrug of psilocin. It is a serotonin receptor (5-HT2A) agonist and known psychedelic, with similar hallucinatory properties to lysergic acid diethylamide (LSD). It has been identified as a safe and effective optio...
| Published in: | European Psychiatry |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2021-04-01
|
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S0924933821011147/type/journal_article |